Showing results (91-100 of 10,674) with videos related to
Sort By:
Pageof 1,068
Neurourology and Urodynamics|August 8, 2015
Age-related changes in bladder function with altered angiotensin II receptor mechanisms in ratsKenichi Mori, Mitsuru Noguchi, Shohei Tobu, et al.American Journal of Physiology. Renal Physiology|November 3, 2017
BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivityMahendra P Kashyap, Subrata K Pore, William C de Groat, et al.International Journal of Molecular Sciences|June 26, 2025
Metabolic Reprogramming of Urothelial Carcinoma-A Theragnostic Target for Betulinic AcidAnirban Ganguly, Aratrika Halder, Keara Healy, et al.Journal of Inflammation (London, England)|August 21, 2009
Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitisPradeep Tyagi, Vikas Tyagi, Naoki Yoshimura, et al.Human Gene Therapy|July 24, 2015
Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in RatsTsuyoshi Majima, Yasuhito Funahashi, Shun Takai, et al.The Journal of Urology|December 11, 2003
Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomesPradeep Tyagi, Michael B Chancellor, Zhenhua Li, et al.International Urology and Nephrology|May 1, 2015
Urine chemokines indicate pathogenic association of obesity with BPH/LUTSPradeep Tyagi, Saundra S Motley, Mahendra Kashyap, et al.International Urology and Nephrology|September 21, 2014
Advanced therapeutic directions to treat the underactive bladderPhillip P Smith, Pradeep Tyagi, George A Kuchel, et al.American Journal of Physiology. Renal Physiology|October 1, 2019
Therapeutic effects of inhibition of brain-derived neurotrophic factor on voiding dysfunction in mice with spinal cord injuryNaoki Wada, Takahiro Shimizu, Nobutaka Shimizu, et al.Neurourology and Urodynamics|October 5, 2016
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injuryKatsumi Kadekawa, Tsuyoshi Majima, Naoki Kawamorita, et al.Pageof 1,068